Tami Mark

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter

Filter by Type

Filter by Focus Area

Filter by Solution

Filter by Center

Search Results

A Decade of Data Tracked the Quality of Addiction Treatment Centers Over Time and Across States Using Federal Government’s ‘Signs’ of Higher Quality

Prior Authorization for Common Opioid Use Disorder Medications Associated with More Adverse Health Outcomes, Study Finds

RTI Study Finds Low Rates of Compliance with Buprenorphine Prescribing Guidelines for Treating Individuals with an Opioid Use Disorder

Association of formulary prior authorization policies with buprenorphine-naloxone prescriptions and hospital and emergency department use among Medicare beneficiaries

Adherence to buprenorphine treatment guidelines among individuals with an opioid use disorder who have private insurance

RTI Launches New Study to Determine Effects of COVID-19 on Access to Addiction Treatment

ATLAS Analytic Findings Webinar

RTI Announces New Fellow Program Appointments and Promotions

Tracking the quality of addiction treatment over time and across states: Using the federal government’s “signs” of higher quality

Prior Authorization for Medications in Medicare Ends Up Increasing Costs

Comparison of Medicaid reimbursements for psychiatrists and primary care physicians

Study Finds No Improvement in Addiction Treatment Initiation and Engagement Rates Among Medicaid and Private Health Plans

Access to and engagement in substance use disorder treatment over time

ATLAS Launches to Help People Find High Quality, Appropriate Addiction Treatment

Paper Offers Policy Recommendations to Mitigate Behavioral Health Consequences of COVID-19 Financial Crisis

Treatment Data: The Linchpin of the New National Treatment Plan for Substance Use Disorder

Expert Available to Comment on COVID-19’s Implications for Addiction Treatment

How to mitigate the mental health care consequences of the COVID-19 financial crisis

Survey of addiction specialists' use of medications to treat alcohol use disorder

‘Cries for Help’: Drug Overdoses Are Soaring During the Coronavirus Pandemic